The Toll-like-receptor 9 agonist DIMS0150 demonstrates therapeutic efficacy for the patient-reported outcome measures PRO-2 and ClinPRO in moderate-to-severe active ulcerative colitis

Saved in:
Bibliographic Details
Main Authors: Atreya, R, Bloom, S, Scaldaferi, F, Gerardi, V, Admyre, C, Karlsson, A, Knittel, T, Kowalski, J, Lukas, M, Lofberg, R, Petryka, R, Schnabel, R, Seidler, U, Nancey, S, Neurath, M, Hawkey, C
Format: Conference Proceeding
Language:English
Subjects:
Medicin och hälsovetenskap
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946